NovaBay Pharmaceuticals has announced its rebranding to Stablecoin Development Corporation, marking a significant pivot in its business focus. The company is reportedly placing a strong emphasis on Sky Protocol, indicating a strategic move into the stablecoin sector. This development highlights a traditional company's shift towards the digital asset market, specifically targeting stablecoin technology and its associated development, according to reports.

NovaBay Pharmaceuticals has announced its rebranding to Stablecoin Development Corporation, marking a significant pivot in its business focus. The company is reportedly placing a strong emphasis on Sky Protocol, indicating a strategic move into the stablecoin sector. This development highlights a traditional company's shift towards the digital asset market, specifically targeting stablecoin technology and its associated development, according to reports.